Company / Revenue
CLOVER HEALTH INVESTMENTS, CORP. /DE Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.9B
FY2025
5-year range
$1.1B / $1.9B
FY2021-FY2025
Trend
+40.3%
vs FY2024
Sector context
#82 of 155
Health Care
What the data says
At $1.9B, CLOVER HEALTH INVESTMENTS, CORP. /DE's revenue ranks #82 of 155 in the Health Care sector. Revenue has increased for 3 consecutive years, from $1.1B in FY2022 to $1.9B in FY2025.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +23.4%.
Improved from $1.3B to $1.9B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +20.6%
- 5-Year CAGR
- +23.4%
- 10-Year CAGR
- -
Sector benchmark
#82 of 155 in Health CareTop 53% of 155This company $1.9B Sector average $19.1B
▼
-89.9% below sector average
Key checks
Key Insights
- CLOVER HEALTH INVESTMENTS, CORP. /DE's revenue has grown for 3 consecutive years.
- 5-year CAGR of +23.4%, indicating consistent growth.
- In FY2025, revenue increased 40.3% year-over-year.
- Ranks #82 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | +40.3% |
| FY2024 | $1.4B | +8.8% |
| FY2023 | $1.3B | +15.0% |
| FY2022 | $1.1B | -25.5% |
| FY2021 | $1.5B | +118.8% |
| FY2020 | $672.9M | +45.6% |
| FY2019 | $462.3M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026